Feasibility Study of Metformin Therapy in ADPKD

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This study is being done to determine if treatment with metformin, a drug widely used for the treatment of diabetes type 2, is safe and well tolerated by individuals with Autosomal Dominant Polycystic Kidney Disease (ADPKD) who are not diabetic and who have slightly decreased kidney function. The study will also evaluate the effects of metformin on kidney growth and kidney function.
Epistemonikos ID: b09305c993cbc72a383d4af782a46765326da0e7
First added on: May 17, 2024